◆ NeutralMIST

Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire Inc.·
Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Milestone Pharmaceuticals Inc. granted 288,000 stock options to six new employees as a material inducement for hiring. The options have an exercise price of $1.32 per share and vest over four years, with 25% vesting after one year followed by monthly installments. The grants were made under the company's 2021 Inducement Plan in compliance with Nasdaq regulations.

Read Full Article at GlobeNewswire Inc.
← Back to Financial Intelligence